DA-302168S
2024-CP-DA168-06
Phase 2 small_molecule active
Quick answer
DA-302168S for Overweight and Obesity is a Phase 2 program (small_molecule) at Chendu DIAO Pharmaceutical Group CO., LTD. with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Chendu DIAO Pharmaceutical Group CO., LTD.
- Indication
- Overweight and Obesity
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- active